COMMD8 antibody (C-Term)
Quick Overview for COMMD8 antibody (C-Term) (ABIN6746485)
Target
See all COMMD8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human COMMD8
-
Predicted Reactivity
- Percent identity by BLAST analysis: Horse, Guinea pig, Xenopus (91%) Dog (85%) Chicken (83%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human COMMD8 (Q9NX08, NP_060315). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%), Gibbon, Monkey, Marmoset (92%), Horse, Opossum, Guinea pig, Xenopus (91%), Elephant, Panda, Dog, Rabbit, Pig (85%), Pike (84%), Turkey, Chicken (83%), Mouse, Rat (78%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
: "Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1." in: The Journal of biological chemistry, Vol. 277, Issue 12, pp. 10346-53, (2002) (PubMed).
: "Prevention of phosphatidylinositol 3'-kinase-Akt survival signaling pathway during topotecan-induced apoptosis." in: Cancer research, Vol. 60, Issue 18, pp. 5303-9, (2000) (PubMed).
-
: "Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1." in: The Journal of biological chemistry, Vol. 277, Issue 12, pp. 10346-53, (2002) (PubMed).
-
-